Meriem Messaoudene

Meriem Messaoudene PhD, is a post-doc in Dr. Bertrand Routy’s laboratory “oncomicrobiome” at the CRCHUM (Montréal, Canada). She specialized in the impact of the microbiome on immunotherapy response. After studying basic immunology at the UPMC and Institut Pasteur (Paris), she went on to complete a PhD at the Université Paris-Saclay on the role of NK cells in human metastatic melanoma. She then continued during two years with a postdoctoral fellowship in Pr. Laurence Zitvogel’s lab (Institut Gustave Roussy. She is now focusing on the impact of Castalagin prebiotic on the gut microbiota and immune response to anti-PD-1 therapy.